Moreover, silencing of both cortactin and HS1 in CLL cells had an additive effect on the inhibition of Wnt5a-enhanced chemokine-directed migration that was significantly greater than that achieved by silencing either cortactin or HS1 alone. The gene discussed is CTTN; the disease is B-cell chronic lymphocytic leukemia.